ICD-10-CM Billable Code

C50.4

Malignant neoplasm of upper-outer quadrant of breast

Clinical Classification Guidelines

Medical Intelligence & Overview

C50.4 refers to a malignant tumor located in the upper-outer quadrant of the breast. This area is a common site for breast cancer development. Understanding this diagnosis involves recognizing its causes, symptoms, and available treatments to provide clarity for patients diagnosed with this condition.

Causes & Symptoms

Clinical Causes: Genetic mutations inherited from family members Hormonal factors leading to increased estrogen levels Lifestyle factors such as alcohol consumption, obesity, and lack of physical activity Environmental exposures to carcinogens Age, with risk increasing as women grow older Previous history of benign breast disease Radiation exposure to the chest area

Key Symptoms: Lump or mass in the upper-outer part of the breast Change in the size, shape, or appearance of the breast Skin changes over the affected area such as redness or dimpling Nipple changes including inversion or discharge Persistent pain or discomfort in the breast region Swelling or a lump in the armpit due to lymph node involvement

Diagnostic & Treatment

Diagnosis Path: Clinical breast examination by a healthcare provider Mammography to visualize abnormal areas within the breast tissue Ultrasound imaging to evaluate the nature of the lump Biopsy procedures, such as fine-needle aspiration or core biopsy, to obtain tissue samples for pathology Magnetic Resonance Imaging (MRI) for detailed assessment if necessary Blood tests to check overall health and evaluate for markers associated with breast cancer

Treatment Protocols: Surgical options such as lumpectomy (removal of the tumor and surrounding tissue) or mastectomy (removal of the entire breast) Radiation therapy to target remaining cancer cells after surgery Chemotherapy to destroy cancer cells systemically, especially in advanced stages Hormone therapy for tumors that are hormone receptor-positive, blocking estrogen or progesterone effects Targeted therapy aimed at specific molecular markers on cancer cells Immunotherapy to enhance the body's immune response against cancer

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.4 a billable ICD-10 code?
Yes, C50.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.4?
Clinical documentation must specify the nature of Malignant neoplasm of upper-outer quadrant of breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference